Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region

Imipenem-relebactam (I-R) is a recently developed carbapenem–beta-lactamase inhibitor combination agent that can overcome carbapenem resistance, which has now emerged in Escherichia coli, including sequence type 131 (ST131) and its fluoroquinolone-resistant H30R subclone, the leading cause of extrai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrob Agents Chemother
Hauptverfasser: Johnston, Brian D., Thuras, Paul, Porter, Stephen B., Anacker, Melissa, VonBank, Brittany, Vagnone, Paula Snippes, Witwer, Medora, Castanheira, Mariana, Johnson, James R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2020
Schlagworte:
Epidemiology and Surveillance
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7179611/
https://ncbi.nlm.nih.gov/pubmed/32152073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02408-19
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge